Wed, January 26, 2011
Tue, January 25, 2011
Mon, January 24, 2011
[ Mon, Jan 24th 2011 ]: Market Wire
00 pm ET
Fri, January 21, 2011
Thu, January 20, 2011
Wed, January 19, 2011
Tue, January 18, 2011
Mon, January 17, 2011
Fri, January 14, 2011
[ Fri, Jan 14th 2011 ]: Market Wire
00 p.m. PST (5:00 p.m. EST)
Thu, January 13, 2011
[ Thu, Jan 13th 2011 ]: Market Wire
Mortgage Rates Mostly Lower
Wed, January 12, 2011
[ Wed, Jan 12th 2011 ]: Market Wire
CAPSA
Tue, January 11, 2011
Mon, January 10, 2011
Fri, January 7, 2011
[ Fri, Jan 07th 2011 ]: Market Wire
30 A.M. Eastern Standard Time
Thu, January 6, 2011
Wed, January 5, 2011

Simulations Plus Sets Date for 1st Quarter 2011 Earnings Release and Conference Call


  Copy link into your clipboard //science-technology.news-articles.net/content/2 .. r-2011-earnings-release-and-conference-call.html
  Print publication without navigation Published in Science and Technology on by Market Wire
          🞛 This publication is a summary or evaluation of another publication

LANCASTER, Calif.--([ BUSINESS WIRE ])--Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of software and consulting services for pharmaceutical R&D and environmental toxicology, announced that it expects to file its quarterly report on Form 10-Q for the first quarter of its 2011 fiscal year, ended November 30, 2010, with the U.S. Securities and Exchange Commission on Thursday, January 13, 2011. Chairman and CEO Walt Woltosz will host a conference call to discuss the Companya™s performance on Friday morning, January 14, at 8:00 a.m. PST / 11:00 a.m. EST.

The conference call will also be webcast live and may be accessed by first registering at the following website: [ https://www2.gotomeeting.com/register/911775626 ]. Upon registering, you will receive a confirmation e-mail with a unique link and instructions for joining the call. Please dial in five to ten minutes prior to the scheduled start time. For listen-only mode, you may dial 516-453-0014 and enter access code 481-048-688.

About Simulations Plus, Inc.

Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery, development, and modeling software, which is licensed and used worldwide for drug research by pharmaceutical, biotechnology, and drug delivery companies and in the study of environmental toxicology, as well as two retail products, Abbreviate! and FutureLaba". The Companya™s Words+ subsidiary provides assistive technologies for persons with disabilities. Simulations Plus, Inc., is headquartered in Southern California and trades on the NASDAQ Capital Market under the symbol aSLP.a For more information, visit our Web site at [ www.simulations-plus.com ].


Publication Contributing Sources